Format

Send to

Choose Destination
See comment in PubMed Commons below
Neurosci Lett. 2001 Apr 27;303(1):17-20.

The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat.

Author information

1
Departments of Psychiatry and Pharmacology and Center for Molecular Neuroscience, Vanderbilt, University Medical Center, Nashville, TN 37212, USA. jim.fadel@mcmail.vanderbilt.edu

Abstract

Neurotensin interacts with central dopamine systems and has been suggested to exert antipsychotic drug-like actions. Antipsychotic drugs such as haloperidol induce striatal immediate-early gene expression. In order to study neurotensin's role in antipsychotic drug actions, rats were pretreated with the neurotensin antagonist SR 48692 and then injected with haloperidol. SR 48692 dose-dependently decreased haloperidol-elicited immediate-early gene expression in the dorsolateral and central striatum but not other striatal areas. SR 48692 reduced Fos expression in the striatal patch (striosome) and matrix compartments, with a significantly greater effect in the patch. These data suggest that neurotensin may play a role in the actions of haloperidol. In view of proposed functional roles of the striatal patch and matrix, we suggest that neurotensin may be important in the therapeutic rather than side effects of antipsychotic drugs.

PMID:
11297813
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center